Here we describe a novel gene trap protocol to screen for target genes that are regulated during inductive events in undifferentiated and differentiated mouse embryonic stem cells. This approach integrates several features that allows in vitro screening of large numbers of gene trap clones prior to generating lines of mutant mice. Moreover, targets of spatially and temporally restricted signaling pathways can be analyzed by screening undifferentiated ES cells versus ES cells differentiated into embryoid bodies. We employed this protocol to screen 1920 gene trap lines to identify targets and mediators of signaling through three growth factors of the TGFb superfamily -BMP2, activin and nodal. We identified two genes that are induced by BMP2 in a differentiation-dependent manner. One of the genes encodes for Chondroitin-4-sulfotransferase and displays a highly specific temporal and spatial expression pattern during mouse embryogenesis. These results demonstrate the feasibility of a high-throughput gene trap approach as a means to identify mediators and targets of multiple growth factor signaling pathways that function during different stages of development. q
Introduction
An important theme in the development of an organism is communication between cells utilizing conserved families of secreted signaling molecules. One of the largest of these families is the transforming growth factor beta (TGFb) superfamily, which includes the bone morphogenic proteins (BMPs), activin and nodal Klüppel et al., 2000; Massague, 2001) . Signaling through these molecules has been shown to play important roles in diverse biological processes. Recently, significant progress has been made in identifying components of the Smad signal transduction pathways that are activated in response to TGFb and BMPs. It has been shown that receptor-activated Smad proteins are phosphorylated and translocated into the nucleus, where, in combination with transcription factors, they are thought to activate genetic programs that confer specific cellular and developmental responses Klüppel et al., 2000; Massague, 2001) . Some of the biggest gaps in our present knowledge of TGFb and BMP signaling relates to the components of these programs. While a number of TGFb and BMP-regulated target genes have been described (Labbe et al., 1998; Tang et al., 1998; Hollnagel et al., 1999; Feng et al., 2000; Seoane et al., 2001) , the function of many of these targets in mediating diverse biological responses to the TGFb superfamily is unclear.
With the availability of whole genome sequences, experimental approaches for a streamlined and high-throughput functional genome analysis are crucial for a complete understanding of the information contained in genomes and the mechanisms by which cells utilize this information. Gene trapping is a well-established approach to identify and mutate genes through a random integration of a gene trap vector into the genome (Skarnes et al., 1992; Stanford et al., 2001) . Integration into an intron of a transcriptionally active gene leads to the generation of a fusion transcript by spli-cing upstream sequences of the endogenous locus to the bgalactosidase reporter gene of the gene trap vector. The consequences of the integration are three-fold: the trapped gene can be identified by 5 0 rapid amplification of cDNA ends (RACE); the expression pattern of the endogenous locus are recapitulated by lacZ expression; and the integration event has the potential to be mutagenic; thus, the biological consequences of the inactivation of the trapped gene can be analyzed after germ line transmission of this ES cell clone (Skarnes et al., 1992) . However, many gene trap protocols described in the past have limitations that either do not allow pre-screening to identify clones of interest (Wurst et al., 1995) , and/or are specific for either undifferentiated ES cells or differentiated embryoid bodies (EBs) (Wurst et al., 1995; Stanford et al., 1998) . In addition, few screens have utilized gene trap approaches to identify target genes of signaling pathways (Forrester et al., 1996; Harrison and Miller, 1996; Akiyama et al., 2000; Medico et al., 2001) . Here, we have integrated several features into the design of an induction gene trap protocol that allows the simultaneous screening of a large number of undifferentiated as well as differentiated ES cell clones for responsiveness to growth factors or other inducing stimuli. These features include the use of 96-well plates throughout the procedure and the differentiation of EBs in a flat culture system (Bautch et al., 1996) . This allows for convenient handling of EBs, easier access of exogenous growth factors and straightforward lacZ staining and microscopic analysis. In a preliminary screen of approximately 2000 ES clones using BMP2, activin and nodal as inducing agents, we identified two BMP2-responsive gene trap lines. We describe the analysis of one line, which incorporated the gene trap vector into the chondroitin-4-sulfotransferase (C4ST ) gene.
Results

A novel high-throughput gene trap screen identifies two BMP2 target genes
The screening procedure is described in Fig. 1 . We utilized the previously described gene trap vector PT-1 (Hill and Wurst, 1993) to electroporate R1 ES cells (step 1). The PT-1 vector contains a promoterless lacZ gene immediately downstream of a splice acceptor (SA) site and the neo R gene driven by the PGK-1 promoter. G418-resistant clones were picked into a gelatinized 96-well tissue culture plate (step 2), that was subsequently split to generate a master plate, which was frozen down for the future recovery of clones of interest, and three additional plates for further analysis (step 3). Two of these were used for induction with either nodal-conditioned medium or control medium to identify genes potentially regulated in undifferentiated ES cells. ES cells in the third plate were dissociated with Dispase and cell clumps transferred to a low cluster 96-well plate, where they were grown in the absence of leukemia inhibitory factor (LIF) (step 4). Under these conditions, ES cell clumps will differentiate into EBs (Keller, 1995) . After 3-4 days of suspension culture, the EBs were transferred back into eight gelatinized 96-well-tissue culture plates, where the EBs adhered to the plate and spread within 12-24 h of culture (step 5). After 2 days of culture, one plate was left untreated as control, while three of the remaining plates were treated with either BMP2, activin-conditioned medium or nodal-conditioned medium for 2 days prior to lacZ staining. Finally, the remaining four plates were used for analysis of growth factor induction at day 14 of EB differentiation.
Using this procedure, we conducted a primary screen of 1920 clones for responsiveness to the growth factors. Although the primary screen resulted in a large number of putative target genes (Table 1) , re-testing of these clones showed that two of the clones consistently demonstrated responsiveness to BMP2 treatment. One clone, 19C4, was induced by BMP2 at day 6 of EB differentiation, but not at day 14, while the second gene trap line, 40E10, was induced by BMP2 at day 14, but not at day 6 of EB differentiation. Fig. 2A) . However, upon BMP2 treatment, the number of lacZexpressing EBs increased approximately three-fold (Fig.  2B ). In contrast, LacZ expression in EBs derived from the 40E10 line was widespread at day 14, and increased considerably after BMP2 treatment (Fig. 2C ). These data demonstrate the feasibility of a high-throughput induction gene trap to identify targets of growth factor signaling at different stages of ES cell diffentiation.
Molecular analysis of the integrations
To characterize the integrations of the gene trap vector, we performed a Southern analysis using genomic DNA from ES clones 19C4 and 40E10. Using a en2/lacZ probe, we observed multiple bands in three different restriction digests of DNA from 19C4, suggesting the presence of multiple integrations in this line (Fig. 3A) . However, similar analysis of 40E10 genomic DNA revealed only one band hybridizing to the lacZ sequence, indicating a single integration of the gene trap vector (Fig. 3A) .
In order to identify the trapped genes, we used the 5 0 -RACE procedure to amplify sequences 5 0 to the integration site using RNA purified from BMP2-treated EBs. Two independent experiments yielded a 280 base pair (bp) product for 19C4 and a 170 bp product for 40E10 (data not shown). Sequence analysis of the RACE products showed that both endogenous sequences were spliced correctly to the splice acceptor site of the gene trap vector (data not shown). The sequence of the 19C4 trapped locus displayed no homology to known sequences in database searches. However, in subsequent Northern and in situ experiments, the 19C4 5 0 RACE product did not detect any mRNAs, while analysis of lacZ expression revealed a lacZ-containing message and tissue-specific expression (data not shown). This suggests that the RACE product we cloned from the 19C4 line does not correspond to the functional gene trap vector integration detected in our lacZ assays. The sequence of the 40E10 trapped locus was identical to the 5 0 sequence of the recently cloned mouse C4ST gene (Yamauchi et al., 2000) , including 50 bp of 5 0 untranslated sequence and 118 bp of 5 0 coding sequence (data not shown). While the genomic organization of the mouse C4ST locus has not yet been published, comparison to the human C4ST locus on chromosome 12 utilizing the NCBI human genome draft revealed that the 40E10 5 0 -RACE product displays high homology to exon 1 of the human C4ST gene. Moreover, a splice donor site conserved between mouse and human genes is utilized to splice exon one of the C4ST gene to the en-2 splice acceptor site of the gene trap vector. These data suggest that in line 40E10 the genetrap vector integrated into the first intron of the C4ST gene. In subsequent studies, we have focused on the analysis of the 40E10 gene trap line.
Quantitation of the induction of 40E10 (C4ST ) by BMP2
To characterize further the regulation of C4ST by BMP2, we performed a Northern analysis using RNA purified from 40E10 EBs that were treated with BMP2 between days 14 and 16 of EB differentiation as well as from untreated control EBs (Fig. 3B ). Hybridization using a lacZ probe revealed a 4.5 kb band in the control cultures that corresponded to the gene-trapped transcript. Further, the intensity of the transcript was stimulated approximately two-fold after BMP-2 treatment. When using the 40E10 5 0 -RACE product as a probe, we detected the 4.5 kb gene trap transcript and a 5.5 kb band that corresponds to the previously published size of the wild type C4ST mRNA. Similar to the lacZ probe, use of the 40E10 probe revealed that BMP2 stimulated expression of both the mutant and wild type C4ST alleles approximately two-fold. We also analyzed the effects of BMP2 on the 40E10 cell line by measuring lacZ activity at various time points after induction using an enzymatic assay. BMP2-treatment led to an approximately 1.7-fold increase in lacZ activity after 48 h of treatment, but had little effects at earlier time points (6 and 24 h; Fig. 4A ). Treatment with BMP7, which activates Smad1 pathways similarly to BMP2 also led to C4ST induction (Fig. 4A ). TGFb also caused induction of C4ST at 48 h (Fig. 4A ). The delayed response to growth factor stimulation suggested to us that C4ST might not be a direct target of the Smad pathway, but rather is induced via an indirect mechanism. To determine if the C4ST gene is a direct transcriptional target of these growth factors, we stimulated 40E10 EBs for 48 h with BMP2, BMP7 or RNA from 40E10 EBs, untreated or treated with 10 nM BMP2 from day 14 to day 16 of EB differentiation, was hybridized to a GAPDH probe, a lacZ probe and a 40E10 RACE product probe. Equal loading is demonstrated by equal intensities of the GAPDH bands. Wt C4ST describes the 5.5 kb mRNA derived from the C4ST allele not harboring the gene trap integration, while gt C4ST (gene-trapped C4ST) describes the 4.5 kb mRNA derived from the C4ST allele carrying the gene trap integration. The lacZ probe only hybridizes to the 4.5 kb gt C4ST mRNA. Treatment of the EBs with 10 nM BMP2 from day 14 to day 16 of EB differentiation leads to an approximately two-fold increase in signal strength of both C4ST mRNA species.
TGFb in the presence or absence of cycloheximide, an inhibitor of protein synthesis. If C4ST was to be a direct target of BMP signaling, the presence of cycloheximide should not interfere with the induction of C4ST expression, since no new protein synthesis would be required for the induction to occur. Quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR) on RNA derived from these EBs showed an approximately two-fold increase in C4ST mRNA levels after treatment with BMP2, BMP7 and TGFb (Fig. 4B ). However, in the presence of cycloheximide, this increase in C4ST expression was abolished (Fig. 4B ), demonstrating that C4ST is an indirect target of signaling through BMP2, BMP7 and TGFb in EBs.
C4ST displays specific temporal and spatial expression patterns during embryogenesis
In order to analyze the expression pattern of C4ST, we generated tetraploid aggregation chimeras using tetraploid wild type blastocysts aggregated with diploid 40E10 ES cells. Under these conditions, the diploid 40E10 ES cells give rise to the embryo, while the tetraploid cells of the blastocyst do not contribute to the embryo and populate extraembryonic tissues (Nagy and Rossant, 1993; Tanaka et al., 2001) . We utilized the resulting embryos to analyze the lacZ expression patterns and compared this to C4ST expression in wild-type embryos by both whole mount and section in situ hybridization.
Expression of C4ST was first observed at day 9.75 of embryogenesis in the apical ectodermal ridge (AER) of the developing limb buds and at the edges of branchial arches 1 and 2, as revealed by both lacZ staining (Fig.  5A ) and whole mount RNA in situ utilizing a C4ST riboprobe (Fig. 5B) . Sectioning of the lacZ-stained embryos revealed highly restricted lacZ expression in the AER (Fig. 5E ) and in the epithelium of the branchial arches (Fig. 5F ). We also detected expression in the ventral neural tube, notochord and sympathetic ganglia (Fig. 5C ) and the mesonephric tubules of the developing kidneys (Fig. 5D ). In the heart, lacZ staining was observed in the myocardium of the atrium (Fig. 5G ) and in the endocardial cushions of both the developing inflow tract and the atrio-ventricular valves. Sectioning of the whole mount in situ embryos similarly revealed expression in the AER, the epithelium of the branchial arches, the endocardial cushion and myocardium of the atrium and the ventral neural tube (data not shown). However, we did not detect expression in notochord, sympathetic ganglia and mesonephric tubules. This may reflect greater sensitivity afforded by lacZ staining when compared to whole mount in situ staining.
We next examined day 15 tetraploid embryos by performing whole mount lacZ staining of sagitally cut day 15 tetraploid embryos (Fig. 6A,B) . This revealed expression of lacZ in the cartilage of developing bones. At higher magnification, lacZ staining was detected in vertebrae and cartilage of the trachea as well as in the thymus (Fig. 6D, E) . In the forelimb, lacZ was expressed in all developing bones, but was absent from developing joint regions and was downregulated in chondrocytes beginning to undergo mineralization, such as in the center of the ulna (Fig. 6I) . These results show that C4ST is broadly expressed in developing chondrocytes. RNA in situ analysis on sectioned day 15 embryos using the C4ST riboprobe also detected prominent staining of cartilage elements (Fig. 6C) . At day 15, we detected no expression in the neural tube. However, tetraploid embryos stained for lacZ at day 13.75 of embryogenesis still showed lacZ expression in the ventral neural tube (Fig. 6D ). This suggests that C4ST expression may be temporally regulated during development of the ventral neural tube. In the heart at day 15, lacZ continued to be expressed in the atrial valve, the atrio-ventricular valves and in the myocardium of the atrium (Fig. 6F, G) , while in the kidney, expression of lacZ was observed in the collecting tubules as well as in Bowman's capsule (Fig. 6H) . Interestingly, the liver displayed a punctate lacZ staining at day 15 (Fig. 6J) , Fig. 4 . Quantitation of the effects of BMP-related growth factors on C4ST expression. (A) b-Gal assays of equal amounts of protein extracts from 40E10 EBs, either untreated or treated with 10 nM BMP2, 5 nM BMP7 or 100 pM TGFb for 6, 24 or 48 h. Treatment for 6 and 24 h was performed in 0.2% EB medium, while the treatment for 48 h is described in Section 4. Treatment with all three growth factors for 48 h from day 14 to day 16 of EB differentiation lead to an approximately 1.7-fold increase in b-Gal enzymatic activity. No significant increase in b-Gal activity was observed after 6 and 24 h of treatment. (B) Quantitative real-time RT-PCR on total RNA from 40E10 EBs treated with BMP2, BMP7 or TGFb for 48 h in the presence or absence of 10 mg/ml cycloheximide, using C4ST-and HPRTspecific primers. All three growth factors increased C4ST expression about two-fold, whereas the addition of cycloheximide abolished this effect.
which was more prominent at day 13.75 (data not shown), suggesting possible expression of C4ST in embryonic hematopoietic cells. Expression was also seen in tooth primordia (Fig. 6A, C) , hair follicles (Fig. 6I ) and mammary glands (data not shown). In situ hybridization utilizing a C4ST riboprobe proved again to be less sensitive than the lacZ staining and only partially recapitulated the lacZ staining pattern. At day 15, C4ST expression was observed in cartilage (Fig. 6C ) and collecting tubules of the kidney (data not shown). However, we were unable to detect C4ST expression in the heart, hair follicles, liver, mammary glands or thymus. At day 13.75, we observed C4ST expression in cartilage and weak expression in the ventral neural tube. Together, these data show that C4ST displays temporally and spatially restricted expression patterns with prominent expression in cells of the chondrocyte lineage.
BMP2 can induce C4ST expression in embryonic tissues
We showed that C4ST expression was induced by BMP in EBs. In order to determine if C4ST might also be a target of BMP signaling in the embryo, we analyzed BMP2-treated explant cultures of whole embryos and various embryonic organs. For this, we produced diploid aggregation chimeras by fusing 40E10 ES cells with R1 morulae and bred male chimeras to wild type ICR female mice. The offspring included both male and female mice heterozygous for the gene trap mutation in the C4ST locus. Heterozygous mice were subsequently bred and organs from day 13.75 heterozygous embryos were collected and cultured for 3 days in the presence or absence of BMP2. Addition of BMP2 to organ cultures containing half of the liver of a heterozygous embryo lead to a strong increase in lacZ staining, whereas the other half, left untreated, showed only punctate staining that was reminiscent of normal C4ST expression at this stage (Fig. 7A) . Similarly, treatment of the left lobe of the lung with BMP2 resulted in prominent lacZ staining, whereas expression was almost absent in the untreated right lobe (Fig. 7B) . In contrast, BMP2 treatment of the right kidney of a heterozygous embryo did not result in increased lacZ staining compared to the untreated left kidney control (Fig. 7C) . These effects were observed in the organ cultures of all heterozygote embryos tested. Heterozygous embryos at day 8.75 were also cultured for 3 days in the presence and absence of BMP2, followed by lacZ staining (Fig. 7D-G) . We detected staining in the neural tube, the AER of the forelimb, otic vesicle, heart and surface ectoderm. We did not observe any effect of BMP2 on C4ST expression at this stage of development (Fig. 7D-G) .
These results demonstrate that BMP2 can regulate C4ST expression in embryonic tissues in a specific spatial and temporal fashion. 
Discussion
Here we describe a high-throughput induction gene trap protocol that allows the screening of large numbers of ES and EB clones for target genes of growth factors. There are several important advantages to this protocol, including the use of 96-well plates throughout the procedure and the differentiation of the EBs in a flat culture system. By grow- Fig. 6 . Expression of C4ST at day 15 of embryogenesis. (A,B) LacZ staining of a tetraploid embryo, cut sagitally during fixation. Expression is seen in cartilage, such as developing ribs (r), nasal bone (nb), basiosphenoid bone (bb), vertebrae (v), and segmented digital rays (d). In addition, lacZ staining is apparent in the heart (h), tooth primordia (tp) and whisker follicles (wf). (C) In situ hybridization on sectioned day 15 embryo utilizing a C4ST riboprobe confirms C4ST expression in cartilage, such as basiosphenoid bone (bb), ribs (r) and vertebrae (v), as well as in tooth primordia (tp). (D-J) LacZ staining of tetraploid embryos. (D) Section of a day 13.75 lacZ-stained tetraploid embryo shows expression in vertebra (v) and ventral neural tube (nt). (E) At day 15, lacZ expression persists in vertebrae, but is no longer present in the neural tube. LacZ staining is also observed in the thymus (th) and the cartilage of the trachea (t). (F) Higher magnification of the heart of the embryo in (A), demonstrating expression in the atrial valve (av), the atrio-ventricular valve (avv) as well as in the atrium (a). ve: ventricle. (G) Section of the heart shown in (F), showing lacZ staining in the atrial valve (av), the atrio-ventricular valve (avv) and the myocardium of the atrium (a). (H) Section of the kidney shows lacZ staining in the collecting tubules (ct) and in Bowman's Capsule (bc). (I) Higher magnification of the forelimb shown in (B). C4ST expression is seen in the cartilage of ulna (ul), radius (ra), metacarpal bones (mc) and phalanges (ph). Expression is absent in the developing joint regions between phalanges and is down-regulated in chondrocytes undergoing mineralization (min). Expression of C4ST is also seen in hair follicles (hf). (J) Punctate lacZ staining in the liver at day 15.
ing both ES cells and EBs in 96-well plates, the protocol facilitates automation and increased throughput. The use of the flat culture system allows the EBs to flatten out and adhere to the plates for convenient manipulation, including growth factor addition and lacZ staining. EBs in flat culture have been shown to differentiate in a similar manner to EBs kept in suspension culture (Bautch et al., 1996) . In addition, responsiveness to growth factors can be tested simultaneously in ES cells and differentiated EBs.
In our initial screen, we established the protocol by using three TGFb-related growth factors as inducing agents. However, simultaneous screening of multiple ligands and/ or other inducing stimuli (i.e. physiological or environmental conditions) in both undifferentiated and/or differentiated ES cells can easily be accomplished by increasing the number of test plates derived from the original 96-well plate of ES cells (Fig. 1, step 2) . In addition to simultaneous analysis of large numbers of growth factors and/or stimuli, it would also be feasible to differentiate the EBs into cell lineages of choice, such as cardiomyocytes or neurons, in order to screen for genes whose expression is modulated during cell fate decisions.
Our primary screen resulted in a relatively high number of false positive clones. This might be due to variability because of the low number of EBs that were plated per well. In future screens, it may be possible to reduce this One half of a liver from a day 13.75 heterozygous embryo was cultured untreated for 3 days, whereas the other half was cultured in the presence of BMP2, followed by lacZ staining. While the untreated tissue piece shows punctate lacZ staining, reminiscent of the C4ST expression in the liver of day 13.75 and day 15 tetraploid embryos ( Fig. 6) , treatment with 10 nM BMP2 lead to strong ectopic expression of C4ST. (B) Lung lobes from a day 13.75 heterozygous embryo were separated and cultured for 3 days in the presence or absence of BMP2. BMP2 treatment induced strong ectopic expression of C4ST in the lung. (C) The kidneys from a day 13.75 heterozygous embryo were cultured in the presence or absence of BMP2 for 3 days. BMP2 treatment did not visibly alter lacZ expression in the collecting tubules in these explant cultures. (D-G) lacZ staining of day 8.75 heterozygous embryos, cultured for 3 days in the absence (D,E) or presence (F,G) of BMP2. Both in the absence (D) and presence (F) of BMP2, expression is seen in the neural tube (black arrowheads), AER of the forelimb (black arrows), the heart and surface ectoderm. (E,G) Viewing the embryos from above, expression in the otic vesicle (white arrowheads), the neural tube (black arrowheads) and the AER (white arrows) is seen both in the absence (E) and presence (G) of BMP2.
by increasing the number of EBs plated. Nevertheless, the re-testing of the clones in the secondary screen to identify true target genes was straightforward and, in our experience, does not represent a major obstacle to throughput. The ratio of BMP-responsive clones per G418-resistant EB clone appears to be in the range expected with the PT-1 vector (approximately 1 in 1000). For example, Vallis et al. (2002) , using the PT-1 vector to screen for radiation-responsive genes in ES cells, identified four radiation-induced clones in 6669 G418-resistant ES clones (1 in 1667), and Wurst et al. (1995) identified 20 retinoic acid-responsive genes in 3600 ES clones (1 in 180). Therefore, our results are expected to be within the range of expected responsive clones using the PT-1 vector in an induction screen.
We identified two gene trap integrations that were induced by BMP2 treatment. We obtained endogenous sequences correctly spliced to the en-2 splice acceptor site for both trapped genes by 5 0 -RACE. However, the 19C4 sequence hybridized to one mRNA species approximately 5 kb in size on a Northern blot containing RNA from the heterozygous 19C4 EBs, but on the same Northern blot, we detected a band of approximately 3.5 kb using a lacZ probe (data not shown). If the 19C4 sequence was derived from a locus with a functional gene trap integration, we would have expected to detect two mRNA species with the 19C4 probe, one of the size of the 19C4 wild type mRNA, and one corresponding to the 3.5 kb mRNA detected by the lacZ probe. Moreover, the 19C4 RACE product did not give an in situ expression profile in embryos at various stages, while we were able to detect expression of lacZ at various stages of embryogenesis (data not shown). This strongly suggests that the 19C4 sequence we obtained does not originate from the correct, lacZ-expressing integration site. Indeed, the 19C4 line has multiple integrations, and we are continuing our analysis of this line to identify the trapped gene that is induced by BMP2. The second BMP2 responsive trapped gene was identified as Chondroitin-4-sulfotransferase (C4ST ). RNA and protein assays showed an approximately two-fold induction of C4ST in EBs in response to BMP2 and two other related growth factors, BMP7 and TGFb. Interestingly, this gene trap line was not responsive to activin or nodal in the original primary screen, suggesting differential regulation by different members of the TGFb superfamily. Cycloheximide experiments showed that C4ST is an indirect target of BMP2, BMP7 and TGFb signaling in EBs, thus explaining the delayed induction of C4ST by these growth factors, which became visible only after 48 h. The C4ST gene has recently been cloned (Yamauchi et al., 2000) , but no data on embryonic expression have been published so far. Our expression analysis of C4ST shows a highly specific temporal and spatial expression pattern, limited to the developing limbs, heart, kidney, liver, neural tube, tooth primordia and skin during embryogenesis. Many of the tissues and cell types expressing C4ST have been shown to require BMP2 for some aspect of their development, thus suggesting that C4ST might also be a target of BMP2 in the embryo. For example, we demonstrated C4ST expression in collecting ducts of the embryonic kidney, and BMP2 has been shown to regulate renal collecting duct morphogenesis (Gupta et al., 2000) . C4ST is expressed in the AER, an important signaling center during limb development, where BMP2 signaling has been implicated in the maintenance of proper Fgf-4 expression in the AER (Zuniga et al., 1999) . At later stages, C4ST expression was observed in the cartilage of all developing bones; BMP2 is an important regulator of chondrogenesis (De Luca et al., 2001; Krishnan et al., 2001) , and recombinant BMP2 can induce ectopic bone formation (Wang et al., 1990; Wang, 1993) . In the heart, C4ST is expressed in the developing inand outflow tract as well as in the atrio-ventricular valve in the heart. BMP2 homozygous mutant mice display a cardiac defect (Zhang and Bradley, 1996) ; moreover, BMP signaling has been implicated in heart valve development (Shi et al., 2000; Abdelwahid et al., 2001; Kim et al., 2001 ) and expression of noggin, a BMP antagonist, in the developing heart leads to outflow tract defects (Allen et al., 2001) . We also observed C4ST expression in tooth primordial, where BMPs play a crucial role in tooth development (Vainio et al., 1993; Neubuser et al., 1997; Tucker et al., 1998) and are able to induce periodontal regeneration (King, 2001) . Finally, BMP signaling has been shown to be required for hair follicle development (Botchkarev et al., 1999; Kulessa et al., 2000) , and we demonstrated C4ST expression in hair follicles.
To investigate the responsiveness of the C4ST gene to BMP signaling in embryonic tissues, we performed explant studies in which embryos or embryonic organs were cultured in the presence or absence of BMP2. While the expression patterns observed in untreated tissues resembled those seen in embryos, treatment with BMP2 lead to strong ectopic expression of C4ST in embryonic liver and lung, but not kidneys derived from day 13.75 heterozygous embryos. C4ST might be under different regulatory mechanisms in the kidney, or endogenous BMP signals are already very high. Consistent with this, BMPs have been shown to be key regulators of kidney development (Gupta et al., 2000; Dudley et al., 1995; Luo et al., 1995) . Similarly, the treatment of cultured day 8.75 embryos with BMP2 did not lead to increased lacZ expression. The expression patterns observed in those embryos resembled closely the C4ST expression we described for day 10 embryos, including the neural tube, heart and AER (Fig. 5) . The lack of induction of C4ST expression in these embryos might again be explained by different regulatory mechanisms at this stage of development or by the already high levels of endogenous BMP signals in the C4ST-positive tissues.
Together, these data show that C4ST is a target gene of BMP signaling not only in EBs, but also in embryos during the development of various tissues. We are currently generating and analyzing mice homozygous for this gene trap mutation to investigate the role of C4ST during mouse development and its potential role as a mediator of BMP signaling.
The data presented here demonstrate the feasibility of a high-throughput induction gene trap protocol to identify genes that are regulated by external cues. This opens up the possibility to screen a large number of ES cells and/or EBs simultaneously for responsiveness to a whole battery of growth factors as well as other stimuli. We are currently using this protocol on a larger scale to identify target genes for a number of growth factors of the TGFb superfamily.
Materials and methods
Primary gene trap screen
R1 ES cells were electroporated with the PT-1 gene trap vector (Hill and Wurst, 1993) as previously described (Wurst and Joyner, 1993) . G418-resistant clones were picked into gelatinized 96-well tissue culture plates. After selection for 8 days, cells were split into four gelatinized 96-well tissue culture plates. One master plate was frozen down for subsequent recovery of clones of interest. ES cells were induced with 50 ml ES medium containing 10% nodalconditioned medium from Mv1Lu cells transfected with a nodal expression construct (A. Mehra, L. Attisano and J.L.W., unpublished results) and 0.2% fetal bovine serum (FBS) for 22 h, followed by the addition of 50 ml ES medium containing 10% nodal-conditioned medium and 15% FBS, and incubation for another 24 h, followed by lacZ staining as previously described. One control plate was treated identically except for the addition of 10% supernatant of untransfected Mv1Lu cells instead of the nodalconditioned medium. We started induction in 0.2% medium to reduce signaling initiated by TGFb-like growth factors contained in the serum, and switched to 15% serum after 22 h to allow the cells to recover from the low serum treatment. ES cells to be diffentiated were treated with 50 ml cold PBS/Dispase (Collaborative Research) (1:1) for 4 min, followed by the addition of 200 ml EB medium (ES medium minus LIF). The content of the wells was carefully pipetted up and down to obtain small clumps of cells and transferred to a low cluster-96-well plate (Costar). Under these conditions, the ES cell clumps will develop into EBs. Medium was changed daily; after 3-4 days of suspension culture, the EBs were transferred back into eight gelatinized 96-well-tissue culture plates for the flat culture. After 2 days of this flat culture system (day 6 of EB differentiation), one plate each was treated with either 10 nM BMP2 (Wyeth Research) plus 10% supernatant from untransfected Mv1Lu cells, 10% activin-conditioned medium (J.L.W., unpublished results) or 10% nodal-conditioned medium for 22 h in 50 ml EB medium containing 0.2% FBS, followed by the addition of 50 ml EB medium containing the growth factors and 15% FBS. Plates were incubated for another 24 h, followed by lacZ staining. Again, one control plate was treated identically, but no growth factor was added. The remaining four plates were used for induction at day 14 of EB differentiation as described for day 6.
Secondary screen
Clones of interest were thawed from the master plate onto primary embryonic fibroblast feeder cells as previously described (Wurst and Joyner, 1993) , expanded onto gelatinized tissue culture plates and retested in multiple wells of 24-well plates for responsiveness to growth factors as described for the primary screen. dilution of the first round PCR product was used as template for a second, nested amplification. The primers for this amplification were as follows: GT-lacZ-3 (5 0 -CGCTC-GAGTCGACCTGTTGGTCTGAAACTCAGCCT-3 0 ) and Universal Amplification (5 0 -CUACUACUACUAGGCCA-CGCGTCGACTAGTAC-3 0 ) (Gibco/BRL). Cycle parameters for both rounds of amplification were as follows: one cycle at 948C for 3 min; 35 cycles at 948C for 1 min, 608C for 2 min and 728C for 3 min; one cycle at 728C for 7 min. RACE-PCR products were digested with SalI and cloned into pBSBluescript. The cDNA inserts were sequenced on both strands using T3 and T7 primers. Sequences were compared against NCBI databases using the BLAST program.
Quantitative real time RT-PCR
Total RNA from treated and untreated 40E10 EBs, induced in the presence or absence of 10 mg/ml cycloheximide (Sigma), was prepared using the Trizol Reagent (Life Technologies) according to the manufacturer's recommendations. Reverse transciption was performed on 1 mg of RNA using the RevertAid H 2 Reverse Transcriptase (Fermentas) and oligo-dT primer. The resulting cDNAs were amplified using the SYBR-Green PCR Master Mix (Applied Biosystems) on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems) according to the manufacturer's recommendations using the following primers Embryos at day 10 of embryogenesis were fixed for 20-30 min; day 15 embryos were fixed for 30-40 min, cut sagitally in half and fixed for another 30-40 min. After fixation, cells and embryos underwent three 20-30-min washes in 2 mM MgCl 2 , 0.02% Triton X-100 and 0.1 M Na 2 HPO 4 (pH 8.0). Subsequently, cells, EBs or embryos were stained with X-Gal (Gibco/BRL) in wash buffer (pH 8.0) containing potassium ferrocyanide and potassium ferricyanide O/N at 378C in the dark (cells and EBs without shaking, embryos with shaking). After the staining, cells were placed in wash buffer and stored for up to several weeks at 48C. Embryos were then fixed in formalin for 24 h, embedded in paraffin and sectioned at 5 mm. Some sections were counterstained with Nuclear Red.
b -Gal enzymatic assay
b-Gal enzymatic activity was measured in cell lysates from untreated and BMP2-treated 40E10 EBs using a chemiluminescence assay as previously described (Tsukazaki et al., 1998) and corrected for protein concentration using the Bio-Rad Protein Assay (BioRad).
Southern analysis
Southern analysis was performed according to the manufacturer's recommendations (ZetaProbe, BioRad). cDNA probes were 32 P-labelled using a oligo-labeling kit from Pharmacia.
Northern analysis
RNA was prepared using the Trizol Reagent (Life Technologies) according to the manufacturer's recommendations. Ten micrograms of total RNA was separated on a 1% Agarose gel containing formaldehyde and transferred to a nylon membrane (ZetaProbe) according to the manufacturer's (BioRad) recommendations. cDNA probes were 32 P-labelled using a oligolabeling kit from Pharmacia. Hybridization and washes were performed according to the manufacturer's recommendations (ZetaProbe, BioRad). The C4ST probe was derived from an expressed sequence tag (EST) clone (IMAGE:659552; Research Genetics) containing 1 kb of mouse C4ST coding sequence.
Generation of diploid and tetraploid aggregation chimeras
Diploid and tetraploid aggregation chimeras were generated as previously described (Nagy and Rossant, 1993) using R1 ES cells.
RNA in situ hybridizations
RNA in situ hybridization on whole mount day 10 embryos was performed as previously described (Belo et al., 1997) . RNA in situ hybridization on sectioned day 15 embryos was essentially performed as previously described (Klüppel et al., 1997) . Probes were labeled using a digoxigenin-labeling system (Roche) according to the manufacturer's recommendations.
Explant cultures
Embryos were genotyped by Southern blot analysis using an en2-lacZ probe. Wild type embryos displayed only an en2 band, but no lacZ band. Embryos heterozygous and homozygous for the gene trap mutation in the C4ST gene displayed both en2 andlacZ bands, with distinct ratios between the signal strengths of the two bands for the two genotypes, since the homozygous embryos have two lacZcontaining alleles, whereas the heterozygous embryos have only one lacZ-containing allele. Day 8.75 heterozygous embryos were cultured in 24-well tissue culture plates (Falcon) for 3 days in EB medium containing 0.2% FBS but no b-mercapto-ethanol. Liver and lung explants from d13.75 heterozygous embryos were cultured in 24-well or 12-well tissue culture plates for 3 days in EB medium containing 0.2% FBS, 1 mM b-glycerophosphate (Sigma) and 0.05 mg/ml ascorbic acid (Sigma), but no b-mercaptoethanol. Kidneys from day 13.75 heterozygous embryos were cultured on 0.4 mm filter inserts (Falcon) in 6-well tissue culture plates for 3 days in EB medium containing 0.2% FBS and 50 mg/ml transferring (Sigma), but no bmercapto-ethanol. All explants were incubated in a tissue culture incubator for 3 h, after which the medium was replaced with control medium or BMP2 (10 mM)-containing medium. Medium was replaced after 36 h. After a total of 72 h incubation in the tissue culture incubator, embryos and tissues were processed for lacZ staining.
